Benign Paroxysmal Vertigo of Childhood: A Long-Term Follow-Up

Cephalalgia ◽  
1994 ◽  
Vol 14 (6) ◽  
pp. 458-460 ◽  
Author(s):  
G Lanzi ◽  
U Balottin ◽  
E Fazzi ◽  
M Tagliasacchi ◽  
M Manfrin ◽  
...  

We examined clinical aspects of Benign Paroxysmal Vertigo (BPV) in infancy and its most frequent differential diagnosis, in particular analogies and differences with forms of “migrainous vertigo” (MV) of later onset. During a long-term follow-up of 7 cases of BPV, diagnosed according to the Basser criteria, 5 of 7 BPV cases spontaneously resolved and 6 of 7 patients later developed migraine and other migraine-related symptoms. This course differs from that described for MV only in the age of onset of headache and in the chronological relationship with vertigo. The authors suggest that BPV can be interpreted as a migraine precursor and MV as a migraine equivalent.

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Shuntaro Oribe ◽  
Takafumi Toyohara ◽  
Eikan Mishima ◽  
Takehiro Suzuki ◽  
Koichi Kikuchi ◽  
...  

Abstract Background Fibromuscular dysplasia (FMD) often causes renal artery stenosis with renovascular hypertension. Recent clinical outcomes encourage percutaneous transluminal renal angioplasty (PTRA) to treat FMD; however, the necessary follow-up period remains unclear. Moreover, previous studies have not revealed the difference in the period until recurrence between two major types of FMD—multifocal and focal. Case presentation We describe two patients with multifocal FMD who developed hypertension during their teenage years and had recurrence of FMD > 10 years after PTRA. We further examined the types of FMD and age of onset in 26 patients who underwent PTRA. The period until recurrence of multifocal FMD was longer than that of focal FMD. Moreover, patients with early-onset multifocal FMD are likely to have a delayed recurrence after PTRA compared to other types. Conclusions Our report suggests that patients with multifocal FMD, especially those with onset at an early age, may need long-term follow-up for at least ≥ 10 years.


PEDIATRICS ◽  
1989 ◽  
Vol 83 (6) ◽  
pp. 986-992
Author(s):  
Yardena Rakover ◽  
Hanna Adar ◽  
Itamar Tal ◽  
Yaron Lang ◽  
Amos Kedar

Behcet disease is rare in children. There are only two reports of Behcet disease in childhood, describing seven patients. Three pediatric patients are described, in whom the age of onset ranged from 6 to 11 years. Aphthous stomatitis and arthritis were present in all of the patients; genital ulcers, iridocylitis, erythema nodosum, and CNS involvement were present in two patients. Other manifestations included Stevens-Johnson-like eruption, fever of unknown origin, and testicular involvement. All of the patients responded to glucocorticoids; two were also treated with colchicine and one was treated with chlorambucil. In two patients, follow-up of more than 10 years was done, with complete cure in one patient and benign course of illness in the other. Because of the rarity of the disease in childhood and the difficulty in making the diagnosis, there is not enough awareness by pediatricians concerning this disease.


1988 ◽  
Vol 11 (11) ◽  
pp. 1575-1583 ◽  
Author(s):  
YASUYUKI SASAKI ◽  
MASAHIRO SHIMOTORI ◽  
KUNIO AKAHANE ◽  
HIROAKI YONEKURA ◽  
KEN HIRANO ◽  
...  

2017 ◽  
Vol 9 (1) ◽  
pp. e2017054
Author(s):  
Kensuke Matsuda ◽  
Yosuke Matsumoto ◽  
Mihiko Yoshida ◽  
Kazuho Shimura ◽  
Hiroto Kaneko ◽  
...  

Hairy B-cell lymphoproliferative disorder (HBLD) is one of chronic polyclonal B-cell lymphocytosis. We report a 47-year-old female Japanese patient diagnosed as having HBLD based on lymphocytosis with hairy cell appearance and characteristic phenotypes including CD11c+, and without B-cell monoclonalities. She was a non-smoker, and possessed HLA-DR4. She has been closely followed up without treatment and lymphoma development for over five years. Although this disease is quite rare and has been reported, to our knowledge, in only 13 Japanese cases, an accurate diagnosis, particularly differential diagnosis from persistent polyclonal B-cell lymphocytosis or hairy cell leukemia-Japanese variant is essential for the prevention of unnecessary treatments.


1980 ◽  
Vol 69 (2) ◽  
pp. 287-308 ◽  
Author(s):  
Peter D. Gorevic ◽  
Hannah Jane Kassab ◽  
Yoram Levo ◽  
Robert Kohn ◽  
Martin Meltzer ◽  
...  

Hernia ◽  
2018 ◽  
Vol 22 (5) ◽  
pp. 881-886 ◽  
Author(s):  
N. Wolfhagen ◽  
N. E. Simons ◽  
K. H. de Jong ◽  
P. J. M. van Kesteren ◽  
M. P. Simons

2008 ◽  
Vol 9 (6) ◽  
pp. 589-592 ◽  
Author(s):  
Geeta Chacko ◽  
Vedantam Rajshekhar

Melanocytomas are tumors of the neuraxis seen predominantly in adults. The authors report a case of a thoracic intramedullary melanocytoma with long-term follow-up of 8 years postsurgery. Melanocytomas, although rare, must be included in the differential diagnosis of intramedullary spinal cord tumors.


2021 ◽  
Author(s):  
Qi Huang ◽  
Feng Li ◽  
Song Zhao

Abstract Background: To investigate the clinical characteristics, treatment and outcomes of myasthenia gravis with antibodies to the muscle-specific tyrosine kinase (MuSK-MG).Methods: We retrospectively reviewed 21 patients with confirmed MuSK-MG between January 2012 to January 2020 in our center. Detailed clinical data and long-term follow up information were summarized.Results: Females (17/21, 81%) predominated in MuSK-MG and the mean age of onset in this group was 51.86±16.16 years. MuSK-MG patients was divided into three subgroups according to the symptom of muscle weakness at onset: ocular myasthenia gravis (OMG, 47.6%), bulbar myasthenia gravis (BMG, 42.9%), and generalized myasthenia gravis (GMG, 9.5%). The mean progression time from symptoms onset to other muscle groups involvement in OMG patients was 4.38±2.54 months. Pyridostigmine bromide was adopted in 81.0% patients and 90.5% patients received corticosteroids. Compared to the usage in hospital, the median daily dose of corticosteroids decreased significantly at the last follow-up. 85.7% patients received a long-term follow-up with an average time of 1202.17 ± 976.73 days. At the end of the follow-up period: 4.8% patient received complete stable remission, 42.9% patients were in minimal manifestations, 19.0% had improved, 4.8% experienced an unchanged condition and 9.5% patients died.Conclusion: Female patients were more prevalent in this study and MuSK-MG patients had a rapid progress to a generalized state. Although about 50% MuSK-MG patients can achieve a favorable outcome with conventional immunosuppressants, complete stable remission is rare and about 15% respond poorly, more effective medications should be explored in these patients.


Sign in / Sign up

Export Citation Format

Share Document